Skip to content

Comparison of the effect of ketorolac and hyosine on pain control in patients with renal colic

A comparative study on the effect of Ketorolac and Hyosine on patients pain controlled with renal colic complications, a randomized control trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100102002954N19
Enrollment
186
Registered
2020-07-01
Start date
2020-07-21
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal colic. A severe paroxysmal pain in the flank radiating to the groin, scrotum or labia, caused by blockage of the renal pelvis or ureter most commonly by a renal stone. May be associated with nausea and vomiting.

Interventions

Intervention 1: Intervention group: for patients in this group, after administration of serum, 30 mg of ketorolac (one ampule) is given intramuscular, and if pain is not controlled within 2 hours, the

Sponsors

Shahroud University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 75 Years

Inclusion criteria

Inclusion criteria: Age between 16 and 75 years of patients; Stable vital signs; Definitive diagnosis of renal colic (with or without urinary tract stones in sonography ); Absence of underlying urinary tract disorders; Do not use any analgesic for 24 hours before visiting; Satisfaction of research participation.

Exclusion criteria

Exclusion criteria: Unstable hemodynamics of patients; History of allergy to ketorolac and hyosine; Evidence of Acute Abdominal Problems (tenderness, guarding, rebind, and rebind tenderness); Pregnancy; Breastfeeding; Renal failure is known; Liver failure is known; A history of active gastric ulcer disease or gastrointestinal bleeding; Addiction to a variety of opium; Dissatisfaction with participating in the project.

Design outcomes

Primary

MeasureTime frame
Reduce the severity of renal pain. Timepoint: Once every hour. Method of measurement: Ask the patient and use the visual analog score (VAS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara kianmehr

Shahroud University of Medical Sciences

sara_kianmehr@gmail.com+98 23 3234 2000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026